Skip to content

TAKEDA BELGIUM

Active
Public limited companyfounded 194581 yrs activeDa Vincilaan 7, 1930 Zaventem, BelgiumKBO/BCE: BE 0403.054.202
Summary

TAKEDA BELGIUM has been active since 1945 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €52.6m and a net result of €4.2m. Equity is growing by ~8.1% per year across the filed fiscal years. Its solvency ranks better than 70% of 5113 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability61▼-16
Solvency89▼-1
Growth53▲+14
Track record100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,000,000 at 30 days acceptable
Liquidity ample (current ratio 2.63 against 2.69 in 2024; short-term debt: 36.3% and cash: 0.1% of total assets), and 36.4% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 81 years 0 90 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
63.6%
Return on assets
5%
Age of the figures
18 mo
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Wholesale trade (NACE 46)
about 21% more bankruptcies
← fewer bankruptcies more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 09-10-2025, 22 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
22 d early
2024
31 d early
2023
15 d early
2022
27 d early
2021
27 d early
2020
16 d late
2019
13 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 17 days before the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today. Usually files around 4 October (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
31-03-2026 close01-10-2026 today31-10-2026 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 11 June 1945, TAKEDA BELGIUM was incorporated.1 In 2012 the company took the name Takeda Christiaens.2 A capital increase in 2013 brought the capital to EUR 5.6 million.3 Nyco Holdings Belgium, Takeda Belgium and Shire Belgium were merged into the company between 2016 and 2020.45 In 2017 the registered office moved to Zaventem.6 Of the 4 current board members, Michael Nesrallah has served longest, since 2022.7 Revenue went from EUR 185 million in 2021 to EUR 201 million in 2025 and headcount from 96.9 to 78.6 full-time equivalents.8

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 22-05-2012
  3. 3Belgian State Gazette, 15-04-2013
  4. 4Belgian State Gazette, 27-09-2016
  5. 5Belgian State Gazette, 04-05-2020
  6. 6Belgian State Gazette, 11-07-2017
  7. 7Belgian State Gazette, 11-04-2022
  8. 8National Bank, annual accounts 2021 and 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, full schema

Turnover
€201.4m▲ 12.0%
2024 · €179.9m
EBIT margin
3.2%▼ 5.6pp
2024 · 8.7%
Net result
€4.2m▼ 61.9%
2024 · €10.9m
Working capital
€48.9m▲ 10.6%
2024 · €44.2m
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Turnover€185.0m▲ 28.4%€141.2m▼ 23.7%€160.4m▲ 13.6%€179.9m▲ 12.2%€201.4m▲ 12.0%
Operating result€69.5m▲ 206%€7.1m▼ 89.7%€7.7m▲ 8.0%€15.7m▲ 104%€6.4m▼ 59.3%
Net result€51.5mabove the sector's middle half▲ 227%€4.8mabove the sector's middle half▼ 90.7%€5.5mabove the sector's middle half▲ 15.0%€10.9mabove the sector's middle half▲ 99.7%€4.2mabove the sector's middle half▼ 61.9%
EBIT margin37.6%▲ 21.8pp5.1%▼ 32.5pp4.8%▼ 0.2pp8.7%▲ 3.9pp3.2%▼ 5.6pp
Equity€27.2mabove the sector's middle half▼ 23.7%€32.0mabove the sector's middle half▲ 17.5%€37.5mabove the sector's middle half▲ 17.1%€48.4mabove the sector's middle half▲ 29.2%€52.6mabove the sector's middle half▲ 8.6%
Total assets€134.0mabove the sector's middle half▲ 97.8%€69.1mabove the sector's middle half▼ 48.5%€68.4mabove the sector's middle half▼ 0.9%€74.8mabove the sector's middle half▲ 9.3%€82.7mabove the sector's middle half▲ 10.6%
Debt€106.6m▲ 236%€36.9m▼ 65.3%€30.8m▼ 16.5%€26.3m▼ 14.8%€30.0m▲ 14.2%
Working capital€20.7mabove the sector's middle half▼ 16.2%€26.4mabove the sector's middle half▲ 27.1%€32.6mabove the sector's middle half▲ 23.5%€44.2mabove the sector's middle half▲ 35.8%€48.9mabove the sector's middle half▲ 10.6%
Solvency20.3%within the sector's middle half▼ 32.4pp46.3%within the sector's middle half▲ 26.0pp54.8%within the sector's middle half▲ 8.4pp64.7%within the sector's middle half▲ 9.9pp63.6%within the sector's middle half▼ 1.1pp
Current ratio1.19within the sector's middle half▼ 0.591.72within the sector's middle half▲ 0.522.06within the sector's middle half▲ 0.342.69within the sector's middle half▲ 0.632.63within the sector's middle half▼ 0.06
Return on assets (ROA)38.5%above the sector's middle half▲ 15.2pp6.9%within the sector's middle half▼ 31.5pp8.0%within the sector's middle half▲ 1.1pp14.6%above the sector's middle half▲ 6.6pp5.0%within the sector's middle half▼ 9.6pp
Staff (FTE)96.9above the sector's middle half▲ 20.4%80.6above the sector's middle half▼ 16.8%76.3above the sector's middle half▼ 5.3%76.4above the sector's middle half▲ 0.1%78.6above the sector's middle half▲ 2.9%
above within below the middle half (P25 to P75) of NACE 46, Wholesale trade, each year against the same schema; no band under 30 filings.
Why a figure moved sharply
  • 2021 Net result +227%, Total assets +98% on 2020. Merger absorbing Shire Belgium, effective 01-04-2020.
Result per fiscal year
Operating resultNet result
€0€20.0m€40.0m€60.0mOperating result 2021: €69.5m€69.5mNet result 2021: €51.5m€51.5mOperating result 2022: €7.1m€7.1mNet result 2022: €4.8m€4.8mOperating result 2023: €7.7m€7.7mNet result 2023: €5.5m€5.5mOperating result 2024: €15.7m€15.7mNet result 2024: €10.9m€10.9mOperating result 2025: €6.4m€6.4mNet result 2025: €4.2m€4.2m20212022202320242025€0€5m€10m€15mOperating result 2023: €7.7m€7.7mNet result 2023: €5.5m€5.5mOperating result 2024: €15.7m€16mNet result 2024: €10.9m€11mOperating result 2025: €6.4m€6.4mNet result 2025: €4.2m€4.2m202320242025
The operating result falls in 2025; 2025 is 59% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €82.7m
Fixed assets €3.8m ▼ 13.4%
Current assets €78.9m ▲ 12.1%
Equity and liabilities €82.7m
Equity €52.6m ▲ 8.6%
Provisions €112,844 =
Debt €30.0m ▲ 14.2%
Debt's share of the balance-sheet total rises from 35.1% to 36.3%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€7.2m▼
2024 · €16.5m
Cash flow
€5.0m▼
2024 · €11.7m
Quick ratio
1.36▼
2024 · 1.51
Debt to equity
0.57▲
2024 · 0.54
ROE
7.9%▼
2024 · 22.6%
Interest coverage
12.28▼
2024 · 343.10
Debt ≤ 1 year
€30.0m▲
2024 · €26.2m
Income taxes
€1.7m▼
2024 · €4.1m
Staff costs
€16.4m▲
2024 · €14.4m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 1,577 companies that looked in July 2024 the way this one looks now, 0.1% went bankrupt within 24 months and 97% are still going.

  • Medium-sized
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.1% went bankrupt
3.1% stopped otherwise
97% still going

For this company itself Checked computes a bankruptcy probability of 0.2% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 1,577 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 73 lines
Balance sheet Code20242025
Assets
Total assets20/58€74.8m€82.7m▲
Fixed assets21/28€4.4m€3.8m▼
Intangible fixed assets21€3.8m€3.1m▼
Tangible fixed assets22/27€444,136€475,217▲
Furniture and vehicles24€119,736€303,939▲
Other tangible fixed assets26€300,976€171,278▼
Assets under construction and advance payments27€23,424-
Financial fixed assets28€226,905€226,905=
Other financial fixed assets284/8€226,905€226,905=
Amounts receivable and cash guarantees285/8€226,905€226,905=
Current assets29/58€70.4m€78.9m▲
Stocks and contracts in progress3€31.0m€38.0m▲
Stocks30/36€31.0m€38.0m▲
Goods purchased for resale34€31.0m€38.0m▲
Amounts receivable within one year40/41€39.0m€40.6m▲
Trade receivables40€39.0m€40.6m▲
Cash at bank and in hand54/58€81,483€87,999▲
Deferred charges and accrued income490/1€371,888€165,301▼
Equity and liabilities
Total equity and liabilities10/49€74.8m€82.7m▲
Equity10/15€48.4m€52.6m▲
Contributions10/11€5.6m€5.6m=
Capital10€5.6m€5.6m=
Issued capital100€5.6m€5.6m=
Reserves13€1.1m€1.1m=
Non-distributable reserves130/1€571,073€571,072=
Legal reserve130€557,785€557,785=
Reserves not available under the articles1311€13,287€13,287=
Tax-exempt reserves132€523,766€523,766=
Profit (loss) carried forward14€41.8m€45.9m▲
Provisions and deferred taxes16€112,844€112,844=
Provisions for liabilities and charges160/5€112,844€112,844=
Pensions and similar obligations160€112,844€112,844=
Amounts payable17/49€26.3m€30.0m▲
Amounts payable within one year42/48€26.2m€30.0m▲
Trade debts44€9.6m€8.5m▼
Suppliers440/4€9.6m€8.5m▼
Taxes, remuneration and social security45€5.8m€5.8m▼
Taxes450/3€795,841€323,912▼
Remuneration and social security454/9€5.0m€5.5m▲
Other amounts payable47/48€10.8m€15.8m▲
Accrued charges and deferred income492/3€86,521-
Income statement Code20242025
Operating income70/76A€194.9m€206.6m▲
Turnover70€179.9m€201.4m▲
Other operating income74€14.9m€5.1m▼
Non-recurring operating income76A-€86,521
Operating charges60/66A€179.1m€200.2m▲
Goods for resale, raw materials and consumables60€132.3m€145.4m▲
Purchases600/8€135.0m€152.0m▲
Change in stocks: decrease (increase)609-€2.7m-€6.6m▼
Services and other goods61€10.2m€10.6m▲
Remuneration, social security and pensions62€14.4m€16.4m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€793,286€831,026▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€32,181-€369,092▼
Provisions for liabilities and charges: additions (uses and reversals)635/8-€818-
Other operating charges640/8€21.4m€27.4m▲
Non-recurring operating charges66A€0-
Operating profit (loss)9901€15.7m€6.4m▼
Financial income75/76B€13,341€34,885▲
Recurring financial income75€13,341€34,885▲
Other financial income752/9€13,341€34,885▲
Financial charges65/66B€681,681€588,319▼
Recurring financial charges65€681,681€588,319▼
Debt charges650€48,096-
Other financial charges652/9€633,585€588,319▼
Profit (loss) for the period before taxes9903€15.0m€5.8m▼
Income taxes67/77€4.1m€1.7m▼
Taxes670/3€4.1m€1.7m▼
Tax adjustments and reversals of tax provisions77€0-
Profit (loss) for the period9904€10.9m€4.2m▼
Profit (loss) for the period to be appropriated9905€10.9m€4.2m▼
Appropriation of the result
Profit (loss) to be appropriated9906€41.8m€45.9m▲
Profit (loss) brought forward from the previous period14P€30.8m€41.8m▲
Social balance
Average headcount (FTE)908776.478.6▲

The notes to these accounts (44 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Operating income70/76A€251.8m€153.8m€166.0m€194.9m€206.6m▲ 6.0%
Turnover70€185.0m€141.2m€160.4m€179.9m€201.4m▲ 12.0%
Other operating income74€16.0m€12.5m€5.6m€14.9m€5.1m▼ 66.1%
Non-recurring operating income76A€50.9m€120,398€0-€86,521-
Operating charges60/66A€182.4m€146.7m€158.3m€179.1m€200.2m▲ 11.8%
Goods for resale, raw materials and consumables60€133.6m€102.2m€113.7m€132.3m€145.4m▲ 9.9%
Purchases600/8€138.5m€111.6m€120.4m€135.0m€152.0m▲ 12.6%
Change in stocks: decrease (increase)609-€4.9m-€9.5m-€6.7m-€2.7m-€6.6m▼ 147%
Services and other goods61€15.6m€15.1m€10.5m€10.2m€10.6m▲ 4.1%
Remuneration, social security and pensions62€18.3m€15.0m€13.7m€14.4m€16.4m▲ 13.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1.1m€1.0m€797,484€793,286€831,026▲ 4.8%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€46,308€606,564€549,061€32,181-€369,092▼ 1,247%
Provisions for liabilities and charges: additions (uses and reversals)635/8-€183,365-€40,421-€11,155-€818--
Other operating charges640/8€13.9m€12.8m€19.1m€21.4m€27.4m▲ 27.9%
Non-recurring operating charges66A--€605€0--
Operating profit (loss)9901€69.5m€7.1m€7.7m€15.7m€6.4m▼ 59.3%
Financial income75/76B€34,867€46,838€13,797€13,341€34,885▲ 161%
Recurring financial income75€34,867€46,838€13,797€13,341€34,885▲ 161%
Income from current assets751€2,330€18,067€0---
Other financial income752/9€32,537€28,771€13,797€13,341€34,885▲ 161%
Financial charges65/66B€32,508€87,664€191,555€681,681€588,319▼ 13.7%
Recurring financial charges65€32,508€87,664€191,555€681,681€588,319▼ 13.7%
Debt charges650--€13,176€48,096--
Other financial charges652/9€32,508€87,664€178,380€633,585€588,319▼ 7.1%
Profit (loss) for the period before taxes9903€69.5m€7.1m€7.5m€15.0m€5.8m▼ 61.2%
Income taxes67/77€17.9m€2.3m€2.1m€4.1m€1.7m▼ 59.3%
Taxes670/3€17.9m€2.3m€2.2m€4.1m€1.7m▼ 59.3%
Tax adjustments and reversals of tax provisions77--€125,540€0--
Profit (loss) for the period9904€51.5m€4.8m€5.5m€10.9m€4.2m▼ 61.9%
Profit (loss) for the period to be appropriated9905€51.5m€4.8m€5.5m€10.9m€4.2m▼ 61.9%
Line20212022202320242025Change
Assets
Total assets20/58€134.0m€69.1m€68.4m€74.8m€82.7m▲ 10.6%
Fixed assets21/28€6.8m€5.9m€5.1m€4.4m€3.8m▼ 13.4%
Intangible fixed assets21€5.9m€5.0m€4.4m€3.8m€3.1m▼ 16.7%
Tangible fixed assets22/27€723,469€678,244€515,969€444,136€475,217▲ 7.0%
Furniture and vehicles24€25,467€112,584€82,651€119,736€303,939▲ 154%
Other tangible fixed assets26€698,002€565,660€433,318€300,976€171,278▼ 43.1%
Assets under construction and advance payments27---€23,424--
Financial fixed assets28€227,853€227,853€226,905€226,905€226,905=
Other financial fixed assets284/8€227,853€227,853€226,905€226,905€226,905=
Amounts receivable and cash guarantees285/8€227,853€227,853€226,905€226,905€226,905=
Current assets29/58€127.2m€63.2m€63.3m€70.4m€78.9m▲ 12.1%
Stocks and contracts in progress3€13.4m€22.3m€28.3m€31.0m€38.0m▲ 22.8%
Stocks30/36€13.4m€22.3m€28.3m€31.0m€38.0m▲ 22.8%
Goods purchased for resale34€13.4m€22.3m€28.3m€31.0m€38.0m▲ 22.8%
Amounts receivable within one year40/41€113.0m€40.7m€34.9m€39.0m€40.6m▲ 4.2%
Trade receivables40€44.2m€36.7m€34.9m€39.0m€40.6m▲ 4.2%
Other amounts receivable41€68.8m€3.9m€24---
Cash at bank and in hand54/58€349€231€2,239€81,483€87,999▲ 8.0%
Deferred charges and accrued income490/1€786,680€148,715€106,996€371,888€165,301▼ 55.6%
Equity and liabilities
Total equity and liabilities10/49€134.0m€69.1m€68.4m€74.8m€82.7m▲ 10.6%
Equity10/15€27.2m€32.0m€37.5m€48.4m€52.6m▲ 8.6%
Contributions10/11€5.6m€5.6m€5.6m€5.6m€5.6m=
Capital10€5.6m€5.6m€5.6m€5.6m€5.6m=
Issued capital100€5.6m€5.6m€5.6m€5.6m€5.6m=
Reserves13€1.1m€1.1m€1.1m€1.1m€1.1m=
Non-distributable reserves130/1€571,073€571,073€571,073€571,073€571,072=
Legal reserve130€557,786€557,785€557,785€557,785€557,785=
Reserves not available under the articles1311€13,287€13,287€13,287€13,287€13,287=
Tax-exempt reserves132€523,766€523,766€523,766€523,766€523,766=
Profit (loss) carried forward14€20.6m€25.3m€30.8m€41.8m€45.9m▲ 10.0%
Provisions and deferred taxes16€165,238€124,817€113,662€112,844€112,844=
Provisions for liabilities and charges160/5€165,238€124,817€113,662€112,844€112,844=
Pensions and similar obligations160€165,238€124,817€113,662€112,844€112,844=
Amounts payable17/49€106.6m€36.9m€30.8m€26.3m€30.0m▲ 14.2%
Amounts payable within one year42/48€106.4m€36.8m€30.8m€26.2m€30.0m▲ 14.5%
Trade debts44€33.5m€9.1m€12.5m€9.6m€8.5m▼ 12.3%
Suppliers440/4€33.5m€9.1m€12.5m€9.6m€8.5m▼ 12.3%
Taxes, remuneration and social security45€8.1m€6.8m€5.8m€5.8m€5.8m▼ 0.3%
Taxes450/3€2.4m€462,483€726,309€795,841€323,912▼ 59.3%
Remuneration and social security454/9€5.7m€6.3m€5.1m€5.0m€5.5m▲ 9.1%
Other amounts payable47/48€64.8m€20.9m€12.5m€10.8m€15.8m▲ 46.5%
Accrued charges and deferred income492/3€161,547€147,026€86,521€86,521--
Line20212022202320242025Change
Profit (loss) for the period9904€51.5m€4.8m€5.5m€10.9m€4.2m▼ 61.9%
+ Depreciation and write-downs630€1.1m€1.0m€797,484€793,286€831,026▲ 4.8%
Operating cash flow (approximation)€52.6m€5.8m€6.3m€11.7m€5.0m▼ 57.4%
Investment in fixed assets (approximation)--€112,930-€8,720-€95,912-€236,566▼ 147%
Change in cash--€118€2,008€79,244€6,516▼ 91.8%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-10-2026
2025
18-12
State Gazette act Resignations & appointments
Power of attorney6 facts ▸
  • Board meeting, 27/11/2025
  • Power of attorney, Wim de Vos
  • Power of attorney, Katrijn Houbracken
  • Power of attorney, Adriana Bustamante
  • Power of attorney, Elke Pittomvils
  • Power of attorney, Lie Chen Ong
07-11
State Gazette act Reappointment: Paul DE PROFT (director)
Mandate compensation3 facts ▸
  • General meeting, 25/09/2025
  • Director reappointment, Paul DE PROFT (director)
  • Mandate compensation, Paul DE PROFT
09-10
NBB filing Annual accounts filed
fiscal year 2025 · full schema
31-03
Financial Weakest financial yearnet €4.2m ▼61.9%
Net result drops to €4.2m, the lowest in the series.
31-03
Financial Equity above €50mEq €52.6m ▲8.6%
7 profitable years in a row build equity to €52.6m.
16-01
State Gazette act Resignation: Paul de Proft (day-to-day manager)
Appointment: Bruno Rabilier (managing director) · Mandate compensation · Power of attorney8 facts ▸
  • Board meeting, 01/01/2025
  • Director resignation, Paul de Proft (day-to-day manager)
  • Director appointment, Bruno Rabilier (managing director)
  • Mandate compensation, Bruno Rabilier
  • Power of attorney, Wim de Vos
  • Power of attorney, Katrijn Houbracken
  • Power of attorney, Adriana Bustamante
  • Power of attorney, Elke Pittomvils
2024
30-09
State Gazette act Appointment: Bruno Rabilier (director)
Mandate compensation3 facts ▸
  • General meeting, 01/09/2024
  • Director appointment, Bruno Rabilier (director)
  • Mandate compensation, Bruno Rabilier
30-09
NBB filing Annual accounts filed
fiscal year 2024 · full schema
25-07
State Gazette act Resignation: Michael Nesraliah (director)
2 facts ▸
  • Shareholder decision, 27/06/2024
  • Director resignation, Michael Nesraliah (director)
2023
22-11
State Gazette act Resignation: Elke Pittomvils (director)
Appointment: Aline Vandecappelle (director) · Mandate compensation4 facts ▸
  • General meeting, 16/10/2023
  • Director resignation, Elke Pittomvils (director)
  • Director appointment, Aline Vandecappelle (director)
  • Mandate compensation, Aline Vandecappelle
31-10
State Gazette act Appointment: KPMG Bedrijfsrevisoren BV (statutory auditor)
2 facts ▸
  • General meeting, 27/09/2023
  • Auditor appointment, KPMG Bedrijfsrevisoren BV (statutory auditor)
16-10
NBB filing Annual accounts filed
fiscal year 2023 · full schema
Show earlier events
2022
04-10
NBB filing Annual accounts filed
fiscal year 2022 · full schema
11-04
State Gazette act Resignation: Laurent Henaux (director)
Appointments: Michael Nesrallah (director) and Paul De Proft (managing director) · Mandate compensation · Power of attorney7 facts ▸
  • General meeting, 07/03/2022
  • Board meeting, 16/03/2022
  • Director resignation, Laurent Henaux (director)
  • Director appointment, Michael Nesrallah (director)
  • Mandate compensation, Michael Nesrallah
  • Power of attorney, Laurent Henaux
  • Director appointment, Paul De Proft (managing director)
2021
04-10
NBB filing Annual accounts filed
fiscal year 2021 · full schema
31-03
Financial Highest result since 2019net €51.5m ▲227%
Operating result €69.5m, net result €51.5m, both a record.
2020
04-12
State Gazette act Appointment: KPMG Bedrijfsrevisoren CVBA (statutory auditor)
2 facts ▸
  • General meeting, 23/10/2020
  • Auditor appointment, KPMG Bedrijfsrevisoren CVBA
16-11
NBB filing Annual accounts filed
fiscal year 2020 · full schema · 16 days late
04-05
State Gazette act Capital & shares · Legal-form change · Restructuring
Merger · Accounting effect · Legal-form conversion9 facts ▸
  • General meeting, 31/03/2020
  • Merger, 01/04/2020
  • Accounting effect, 01/04/2020
  • Legal-form conversion, naamloze vennootschap
  • Purpose change, De vennootschap heeft als voorwerp ... a. de fabricatie ... b. het importeren ... c. het dienen als holdingvennootschap ... d. het oprichten ... e. het leveren…
  • Mandate compensation, HENAUX Laurent
  • Mandate compensation, PITOMVILS Elke
  • Mandate compensation, DE PROFT Paul
  • Capital, €5.577.854,82
13-02
State Gazette act Restructuring
Proposal date · Merger · Accounting effect4 facts ▸
  • Proposal date, 29 januari 2020
  • Merger
  • Accounting effect, 1 april 2020
  • Purpose change, De statutaire zaakvoerder van Takeda BE stelt voor om het huidig maatschappelijk doel van Takeda BE te wijzigen teneinde de activiteiten van Shire BE daarin op…
29-01
State Gazette act Resignation: Takeda Nederland B.V. (statutory manager)
Appointment: Takeda International Holding GmbH (statutory manager) · Permanent representatives: OVERKAMP Aarnoud and STOSSEL Peter · Mandate compensation7 facts ▸
  • General meeting, 19-12-2019
  • Director resignation, Takeda Nederland B.V. (statutory manager)
  • Director appointment, Takeda International Holding GmbH (statutory manager)
  • Permanent representative, OVERKAMP Aarnoud
  • Permanent representative, STOSSEL Peter
  • Mandate compensation, Takeda International Holding GmbH
  • Statutes amendment
2019
18-10
NBB filing Annual accounts filed
fiscal year 2019 · full schema
30-07
State Gazette act Capital & shares
Registered-office move · Capital reduction · Statutes amendment5 facts ▸
  • General meeting, 17/07/2018
  • Registered-office move, 1930 Zaventem, L. Da Vincilaan 7
  • Capital reduction, Reële vermindering van de uitgiftepremies
  • Statutes amendment
  • Language change, Nederlands
06-02
State Gazette act Resignations & appointments
Power of attorney2 facts ▸
  • Power of attorney, Gundula Schneidewind
  • Power of attorney, Laurent Henaux
2018
05-10
NBB filing Annual accounts filed
fiscal year 2018 · full schema
2017
12-12
State Gazette act Resignations & appointments
Address change2 facts ▸
  • Board meeting, 22 november 2017
  • Address change, 24 oktober 2017
03-11
State Gazette act Appointment: KPMG Bedrijfsrevisoren Burg. CVBA (statutory auditor)
Permanent representative: Axel Jorion · Mandate compensation4 facts ▸
  • General meeting, 06/10/2017
  • Auditor appointment, KPMG Bedrijfsrevisoren Burg. CVBA (statutory auditor)
  • Permanent representative, Axel Jorion (permanent representative)
  • Mandate compensation, KPMG Bedrijfsrevisoren Burg. CVBA
23-10
State Gazette act Resignations & appointments
Power of attorney4 facts ▸
  • Board meeting, 28/09/2017
  • Power of attorney, Gundula SCHNEIDEWIND (dagselijks bestuur)
  • Power of attorney, Paul DE PROFT (dagselijks bestuur)
  • Power of attorney, Paul Maris (dagselijks bestuur)
12-10
NBB filing Annual accounts filed
fiscal year 2017 · full schema
11-07
State Gazette act Registered office · Resignations & appointments
Registered-office move2 facts ▸
  • Board meeting, 08/06/2017
  • Registered-office move, L. Da Vincilaan 7, 1930 Zaventem
11-05
State Gazette act Permanent representative: Aarnoud OVERKAMP
2 facts ▸
  • Board meeting, 26/04/2017
  • Permanent representative, Aarnoud OVERKAMP
2016
27-09
State Gazette act Appointment: Takeda Nederland B.V. (manager)
Statutes amendment · Capital4 facts ▸
  • General meeting, september 2016
  • Statutes amendment
  • Capital, €5.577.854,82
  • Director appointment, Takeda Nederland B.V. (manager)
14-09
NBB filing Annual accounts filed
fiscal year 2016 · full schema
13-07
State Gazette act Restructuring
Merger · Accounting effect · Share transfer5 facts ▸
  • Merger, fusion par absorption, article 676 juncto les articles 719 jusqu'à 727 (inclus) du Code des sociétés
  • Accounting effect, 01/04/2016
  • Share transfer, TAKEDA NEDERLAND B.V. → TAKEDA CHRISTIAENS
  • Statutory modification, L'article 4 des statuts de la Société Absorbante concernant son objet social sera modifié afin de le mettre en conformité avec l'objet social de la Société Abso…
  • Tax declaration, Application des articles 211 et suivants du Code des impôts sur les revenus 1992 et des articles 11 et 18, §3 du Code de la TVA.
13-07
State Gazette act Restructuring
Merger · Accounting effect · Share transfer6 facts ▸
  • Merger, fusion par absorption, article 676 juncto les articles 719 jusqu'à 727 (inclus) du Code des sociétés
  • Accounting effect, 01/04/2016
  • Share transfer, Takeda Nycomed AS → TAKEDA CHRISTIAENS
  • Statute modification, Article 4 (objet social) modifié pour le mettre en conformité avec l'objet social de la Société Absorbée
  • Tax declaration, Application des articles 211 et suivants du Code des impôts sur les revenus 1992
  • Dissolution, Nyco Holdings Belgium cesse d'exister
2015
31-03
State Gazette act Resignation: Takeda Nederland B.V. (director)
Appointment: Takeda Nederland B.V. (manager) · Permanent representative: Jan Herman Timmermans · Statutes amendment5 facts ▸
  • General meeting, 24/02/2015
  • Director resignation, Takeda Nederland B.V. (director)
  • Director appointment, Takeda Nederland B.V. (manager)
  • Permanent representative, Jan Herman Timmermans
  • Statutes amendment
30-01
State Gazette act Appointment: KPMG Réviseurs d'Entreprises (statutory auditor)
2 facts ▸
  • General meeting, 02/07/2014
  • Auditor appointment, KPMG Réviseurs d'Entreprises (statutory auditor)
2014
11-04
State Gazette act Resignations: Takeda Nederland B.V. (director) and Marc Lorimier (director)
Appointments: Anders John Krüger (director) and Claus van der Stouwe (director) · Director discharge6 facts ▸
  • General meeting, 30/01/2013
  • Director resignation, Takeda Nederland B.V. (director)
  • Director discharge, Takeda Nederland B.V. (director)
  • Director resignation, Marc Lorimier (director)
  • Director appointment, Anders John Krüger (director)
  • Director appointment, Claus van der Stouwe (director)
2013
28-11
State Gazette act Resignations & appointments
Power of attorney5 facts ▸
  • Board meeting, 29/10/2013
  • Power of attorney, Paul MARIS
  • Power of attorney, Paul DE PROFT
  • Power of attorney, Paul MARIS
  • Power of attorney, Paul DE PROFT
12-09
State Gazette act Appointment: Paul MARIS (daily management delegate)
Mandate compensation · Power of attorney4 facts ▸
  • Board meeting, 01/08/2013
  • Director appointment, Paul MARIS (daily management delegate)
  • Mandate compensation, Paul MARIS
  • Power of attorney, Christine JULIAM
15-04
State Gazette act Capital & shares · Statutes amendment
Capital increase · Bank account · Capital5 facts ▸
  • General meeting, 27/03/2013
  • Capital increase, €250,51
  • Bank account, 18/03/2013
  • Capital, €5.577.854,82
  • Statutes amendment
2012
22-05
State Gazette act Resignations & appointments
Name change2 facts ▸
  • General meeting, 08/05/2012
  • Name change, Takeda Christiaens
13-03
State Gazette act Resignations & appointments
Power of attorney10 facts ▸
  • Power of attorney, M. Lorimier
  • Power of attorney, P. Maris
  • Power of attorney, G. Van Wallendael
  • Power of attorney, E. Winckler
  • Power of attorney, P. De Proft
  • Power of attorney, M. Lorimier
  • Power of attorney, P. Maris
  • Power of attorney, G. Van Wallendael
  • Power of attorney, E. Winckler
  • Power of attorney, P. De Proft
17-02
State Gazette act Appointments: Ernst & Young Réviseurs d'Entreprises (statutory auditor) and Klynveld Peat Marwick Goerdeler - Réviseurs d'entreprises (statutory auditor)
Statutes amendment · Accounting effect6 facts ▸
  • General meeting, 20/12/2011
  • Statutes amendment
  • Statutes amendment
  • Accounting effect, L'exercice social actuellement en cours, qui a commencé le premier janvier deux mille onze se terminera le trente et un mars deux mille douze.
  • Auditor appointment, Ernst & Young Réviseurs d'Entreprises (statutory auditor)
  • Auditor appointment, Klynveld Peat Marwick Goerdeler - Réviseurs d'entreprises (statutory auditor)
2011
13-07
State Gazette act Appointment: Ernst & Young Réviseur d'entreprises sccrl (statutory auditor)
Mandate term3 facts ▸
  • General meeting, 04/05/2011
  • Auditor appointment, Ernst & Young Réviseur d'entreprises sccrl (statutory auditor)
  • Mandate term, 3 ans
13-07
State Gazette act Permanent representatives: Herman Timmermans and Mike Egli
2 facts ▸
  • Permanent representative, Herman Timmermans
  • Permanent representative, Mike Egli
2008
05-08
State Gazette act Permanent representatives: Runar Bjørklund and Mike Egli
2 facts ▸
  • Permanent representative, Runar Bjørklund
  • Permanent representative, Mike Egli
01-08
State Gazette act Appointment: Ernst & Young Réviseurs d'Entreprises (statutory auditor)
2 facts ▸
  • General meeting, 22/05/2008
  • Auditor appointment, Ernst & Young Réviseurs d'Entreprises
2007
24-07
State Gazette act Appointment: Ernst & Young Réviseurs d'Entreprises (statutory auditor)
2 facts ▸
  • General meeting, 04/05/2005
  • Auditor appointment, Ernst & Young Réviseurs d'Entreprises (statutory auditor)
2006
11-12
State Gazette act Restructuring · Miscellaneous
Merger1 fact ▸
  • Merger
2002
07-10
State Gazette act Statutes amendment · Miscellaneous
1 fact ▸
  • Statutes amendment
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.An act published in both Dutch and French appears here once.
40 of 40 acts read

Directors · office · real estate

Directors
4 directors, 1 in day-to-day management, no change since 2025

Board 4

Michael Nesrallah
Director · since 07-03-2022
Current
Aline Vandecappelle
Director · since 01-11-2023
Current
Bruno Rabilier
Director · since 01-09-2024
Current
Paul DE PROFT
Director · since 25-09-2025
Current
3 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
Anders John Krüger
Director · since 11-04-2014
Not recently confirmed
Claus van der Stouwe
Director · since 11-04-2014
Not recently confirmed
Takeda International Holding GmbH
Statutory manager · since 19-12-2019 · Legal entity · perm. rep.: STOSSEL Peter
Not recently confirmed

Day-to-day management 1

Bruno Rabilier
Managing director · since 01-01-2025
Current
1 not recently confirmed
Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.
Paul MARIS
Daily management delegate · since 01-08-2013
Not recently confirmed

Permanent representatives 1

STOSSEL Peter
Permanent representative · since 19-12-2019 · for Takeda International Holding GmbH
Not recently confirmed

Statutory auditor 1

KPMG Bedrijfsrevisoren BV
Statutory auditor · since 30-01-2015 · perm. rep.: Axel Jorion
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Zaventem · 1 establishment unit since 1945
seat establishment The establishment unit on the map
Ground area
6,456 m²
Building footprint
1,500 m²
Volume, LiDAR
40,654 m³
Parcel 23094D0081/00D003, Flanders · tallest building 34.9 m, ±10 floors. Linked by address, not a title deed.
14 companies at this address See who is registered here
1 establishment unit
Da Vincilaan 7, 1930 Zaventem
NACE 51460
since 19452.003.160.361
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23094D0081/00D003 Flanders 6,456 m² 1 · 1,500 m² 34.9 m · 10 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

16 people since 2007, 9 in office
Show
  • Board
  • Day-to-day management
  • Statutory auditor
  • not recently confirmed
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
Michael Nesrallah
  • Director, from 07-03-2022 to date
Paul DE PROFT
  • Managing director, from 07-03-2022 to 01-01-2025
  • Director, already before 25-09-2025 to date
Aline Vandecappelle
  • Director, from 01-11-2023 to date
Bruno Rabilier
  • Director, from 01-09-2024 to date
  • Managing director, from 01-01-2025 to date
KPMG Bedrijfsrevisoren BV
  • Statutory auditor, from 30-01-2015 to date
Anders John Krüger
  • Director, from 11-04-2014 not ended, last confirmed 11-04-2014
Claus van der Stouwe
  • Director, from 11-04-2014 not ended, last confirmed 11-04-2014
Takeda International Holding GmbH
  • Statutory manager, from 19-12-2019 not ended, last confirmed 29-01-2020
Paul MARIS
  • Daily management delegate, from 01-08-2013 not ended, last confirmed 12-09-2013
Michael Nesraliah
  • Director, until 27-06-2024
Elke Pittomvils
  • Director, until 01-11-2023
Laurent Henaux
  • Director, until 07-03-2022
Takeda Nederland B.V.
  • Director, until 11-04-2014
  • Manager, from 24-02-2015 to 31-03-2015
  • Manager, from 27-09-2016 to 19-12-2019
Klynveld, Peat, Marwick, Goerdeler - Réviseurs d'Entreprises
  • Statutory auditor, from 17-02-2012 to 30-01-2015
Marc Lorimier
  • Director, until 11-04-2014
Ernst & Young Réviseurs d'entreprises
  • Statutory auditor, from 24-07-2007 to 17-02-2012
See the board, name and seat on a given date →

Articles of association

Purpose
De vennootschap heeft tot doel, voor eigen rekening of voor de rekening van derden, de fabricatie, het voorbereiden, het verpakken en de handel, ongeacht de vorm, van alle…
Full purpose

De vennootschap heeft tot doel, voor eigen rekening of voor de rekening van derden, de fabricatie, het voorbereiden, het verpakken en de handel, ongeacht de vorm, van alle producten, medicijnen, specialiteiten, artikelen en accessoires, bestemd voor farmaceutische, (para)medische, therapeutische, diëtetische, chirurgische doeleinden, van alle chemische producten, van alle hygiëne-, schoonheids-, parfumerie- en drogisterijproducten, inclusief alle studies, onderzoeken en analyses hieraan gerelateerd. De vennootschap kan haar doel op elke plaats, op elke manier en volgens de modaliteiten die haar het meest geschikt lijken, uitvoeren, en meer bepaald alle associatie-, rationalisatie- en samenwerkingsovereenkomsten sluiten, alsmede alle arbeids- en ondernemingsovereenkomsten sluiten, zijn financiële steun verlenen, in welke vorm dan ook, alle werken en studies uitvoeren voor elke onderneming. associatie of vennootschap waarin zij een belang heeft of aan wie zij haar financiële steun verleent heeft. De vennootschap kan het bestuur, het toezicht en de controle, als bestuurder, vereffenaar of in een andere hoedanigheid, in elke verbonden vennootschap of dochtervennootschap uitoefenen, en hen advies verlenen. Zij kan in het algemeen alle commerciële, industriële, financiële of civielrechtelijk handelingen verrichten die rechtstreeks of onrechtstreeks verband houden met haar maatschappelijk doel, of die bijdragen aan haar verwezenlijking, en meer bepaald, zonder dat de volgende opsomming limitatief is, het verwerven, vervreemden, het huren of verhuren van alle roerende of onroerende goederen, het leasen of verpachten van het geheel of een deel van haar uitrusting, exploitaties of handelsfonds, het verwerven, aanmaken, vervreemden van alle fabrieks- of handelsmerken en een belang nemen op elke wijze en op elke plaats, in elke vennootschap of onderneming waarvan het doel analoog of verbonden is met het maatschappelijk doel van de vennootschap of die voor de vennootschap een leverancier of afnemer kan uitmaken. De vennootschap kan, in welke vorm dan ook, diensten leveren met het oog op de studie, het toezicht en het bestuur van alle vermichtingen in de financiële sector. Zij mag eveneens alle leningen verstrekken of alle door derden toegekende leningen aan elke verbonden vennootschap waarborgen, ongeacht de vorm en de termijn van de leningen. De vennootschap kan alles doen wat noodzakelijk is om de andere vennootschappen van de groep bij te staan.

Structure & network

Owners and holdings

2 owners

Chain of control

  1. Takeda Pharmaceutical International AGCH 100%
  2. TAKEDA BELGIUM

Highest known parent: Takeda Pharmaceutical International AG (Switzerland). The sources do not say who stands above it.

Owners 2

Holdings 0

The accounts to 31-03-2025 list no holdings, and no other source names one.

According to the annual accounts to 31-03-2025 of TAKEDA BELGIUM and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

3 connected companies
Depth
This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.
Linked via shared directors
MERCK
Shared director
→
Merck Chemicals NV/SA
Shared director
→
P&G HEALTH BELGIUM
Shared director
→

Ownership & control

1 board mandate
Board mandates of this companythis company sits on their board1

Acquisitions and mergers

4 transactions
Took over:Shire Belgium
BE 0563.700.355operation treated as a merger by absorption · State Gazette act of 04-05-2020 (2 acts) · effective 01-04-2020
BE 0478.867.422operation treated as a merger by absorption · State Gazette act of 27-09-2016 (2 acts) · effective 01-09-2016
Took over:Takeda Belgium
BE 0448.691.613operation treated as a merger by absorption · State Gazette act of 27-09-2016 (2 acts) · effective 01-09-2016
Took over:CENTRAPHARM
proposal · State Gazette act of 11-12-2006

Capital and shareholders

Capital over the years
  1. 04-05-2020 Capital stated in 2 acts · 5,577,854.82 EUR · 22,266 shares
  2. 15-04-2013 Capital increase of 250.51 EUR · to 5,577,854.82 EUR · 1 new share

Subsidies and aid

Flemish government

2022 to 2023 · 2 entries · 1,981 EUR awarded · 1,981 EUR paid
Year Entries awardedpaid
2023 1 341 EUR341 EUR
2022 1 1,640 EUR1,640 EUR
Schemes
2 entries · 1,981 EUR · 1,981 EUR paid · Departement Werk en Sociale Economie

Recognitions · licences · registrations

Legal Entity Identifier

894500TFSGY31Z5ZM673
no longer live in the LEI register

Similar companies · same sector, comparable size

Of 1,901 companies in this sector we hold annual accounts for 1,126. 183 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company details

Identification
Legal formPublic limited company
Founded11-06-1945
Fiscal year end31-03
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
70200Business and other management consultancy
E-invoicing
Reachable via Peppol
Peppol ID 0208:0403054202
Also 9925:BE0403054202
Registered 17-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 1 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.